PepsiCo adds genetics heavyweight to board

• PepsiCo (NASDAQ:PEP) adds David Page to its board of directors.
• Page is the director of a biomedical research group affiliated with MIT and a well-known biology professor at the university.
• He is well-versed in genetics research.